ERC Consolidator Grant · 2025
Three-dimensional bioprinting holds the promise to transform medicine and biology by assembling living matter into lab-made human tissues. Today’s bioprinting excels at producing anatomical shapes, to an extent unmatched by other technologies. However, in native tissues, biological function is intimately linked to architecture, but also tissue maturation and morphogenesis, processes that dynamically evolve as cells respond to environmental stimuli. Bioprinting has no way to follow maturation over time and intervene to guide cells, severely limiting the ability to fully mimic organ functions. Capturing and controlling tissue’s adaptive behaviour in bioprinted tissues can bring the long…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.